|
|
|
¹ÚÁøÈñ ( Park Jin-Hee ) - ¾ÆÁÖ´ëÇб³ °£È£´ëÇÐ
Á¤¿ë½Ä ( Jung Yong-Sik ) - ¾ÆÁÖ´ëÇб³ ÀÇ°ú´ëÇÐ À¯¹æ¿Ü°ú ±èÁö¿µ ( Kim Ji-Young ) - ¾ÆÁÖ´ëÇб³ ÀÇ°ú´ëÇÐ À¯¹æ¿Ü°ú ¹è¼±Çü ( Bae Sun-Hyoung ) - ¾ÆÁÖ´ëÇб³ °£È£´ëÇÐ Á¶À¯Á¤ ( Jo Yu-Jung ) - ¾ÆÁÖ´ëÇб³ °£È£´ëÇÐ
|
|
Abstract
|
|
|
|
Purpose: The aim of this study was to evaluate the severity of menopausal symptoms and their impact on the quality of life (QOL) in breast cancer patients with chemotherapy-induced amenorrhea.
Methods: A cross-sectional survey design was used. Participants were 112 breast cancer patients with chemotherapy-induced amenorrhea. They completed the Menopause Rating Scale (MRS) and the Functional Assessment of Cancer Therapy-General (FACT-G). Data were analyzed using descriptive statistics, independent ttests, one-way ANOVA, Pearson¡¯s correlation coefficients, and multiple regression with SPSS/WIN 23.0.
Results: The prevalence of symptoms among the participants were as follows: sleep problems, 88.4%; physical and mental exhaustion, 80.4%; joint and muscular discomfort, 76.8%; and depression, 70.5%. Menopausal symptoms had a significant negative association with QOL. The results of the regression analysis showed that psychological and urogenital symptoms were statistically significant in explaining patients¡¯ QOL and accounted for 70% of the total variance.
Conclusion: Menopausal symptoms appear to be a significant problem for premenopausal breast cancer patients. Assessment and control of menopausal symptoms played a large role in maintaining the quality of life in breast cancer patients.
|
|
KeyWords
|
|
À¯¹æ¾Ï, °»³â±â, »îÀÇÁú, Ç×¾ÏÈÇпä¹ý
Breast neoplasms, Menopause, Quality of life, Drug therapy
|
|
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
|
|
|
|
µîÀçÀú³Î Á¤º¸
|
|
|
|
|
|